Longer lives now come with more years spent in poor health worldwide
A major global analysis shows that survival gains are outpacing healthy aging, shifting the public health challenge from…
Global childhood IBD trends reveal unequal progress in diagnosis and survival
Behind the sharp fall in deaths, three decades of global data reveal uneven progress and a growing need…
Opioid Prescribing by Pain Specialists on the Rise
TOPLINE Opioid prescribing by pain medicine specialists rose between 2010 and 2024, while prescribing by primary care physicians…
Telehealth mindfulness program reduces chronic low back pain
Low back pain affects over 600 million people and is the single leading cause of disability worldwide. New research from Boston…
Federal grant delays could jeopardize essential disability services, research
The countdown has started. Robert Gould has 73 days before federal funding delays ruin decades of his institution’s…
Autism study reveals shared brain cell changes during early development
Hundreds of genes have been linked to autism, yet the precise molecular and cellular mechanisms behind it remain…
Menopausal hormone therapy linked to stronger bone health
Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not…
Mesothelioma remains deadly despite declining asbestos exposure rates
Mesothelioma deaths and diagnoses continue to rise in the United States despite decades of asbestos regulation and reduced…
Brazil launches genetic screening project for prospective parents
In the coming weeks, the Human Genome and Stem Cell Research Center (HUG-CELL) will begin recruiting participants for the “Our…
People with intellectual disability continue to receive substandard healthcare as programme to train doctors risks closure
The day Sam Stubbs decided he was so unwell he needed to go to hospital was the day…
As FDA misses deadline on electric shock ban, disability advocates speak out
Two years ago, the Food and Drug Administration gave itself a deadline. The agency would eventually decide whether…
Ocrelizumab slows disability progression in advanced progressive multiple sclerosis
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab…